BRPI0816992A2 - Derivado heterocíclico tricícloco, e, composição farmacêutica - Google Patents
Derivado heterocíclico tricícloco, e, composição farmacêuticaInfo
- Publication number
- BRPI0816992A2 BRPI0816992A2 BRPI0816992A BRPI0816992A2 BR PI0816992 A2 BRPI0816992 A2 BR PI0816992A2 BR PI0816992 A BRPI0816992 A BR PI0816992A BR PI0816992 A2 BRPI0816992 A2 BR PI0816992A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- heterocyclic derivative
- tricyclic heterocyclic
- tricyclic
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07116561 | 2007-09-17 | ||
PCT/EP2008/062229 WO2009037220A1 (en) | 2007-09-17 | 2008-09-15 | Tricyclic heterocyclic derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0816992A2 true BRPI0816992A2 (pt) | 2015-03-24 |
Family
ID=39718515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0816992 BRPI0816992A2 (pt) | 2007-09-17 | 2008-09-15 | Derivado heterocíclico tricícloco, e, composição farmacêutica |
Country Status (17)
Country | Link |
---|---|
US (1) | US20100210680A1 (pt) |
EP (1) | EP2203454A1 (pt) |
JP (1) | JP5447380B2 (pt) |
KR (1) | KR20100072027A (pt) |
CN (1) | CN101801980B (pt) |
AR (1) | AR068521A1 (pt) |
AU (1) | AU2008300607B2 (pt) |
BR (1) | BRPI0816992A2 (pt) |
CA (1) | CA2698436A1 (pt) |
CL (1) | CL2008002767A1 (pt) |
CO (1) | CO6260138A2 (pt) |
MX (1) | MX2010002900A (pt) |
NZ (1) | NZ583627A (pt) |
PE (1) | PE20090704A1 (pt) |
RU (1) | RU2010115337A (pt) |
TW (1) | TW200924752A (pt) |
WO (1) | WO2009037220A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8546377B2 (en) * | 2009-04-23 | 2013-10-01 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
US8518933B2 (en) * | 2009-04-23 | 2013-08-27 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
NZ596827A (en) * | 2009-05-22 | 2014-01-31 | Abbott Lab | Modulators of 5-ht receptors and methods of use thereof |
AU2010353724B2 (en) | 2010-05-21 | 2015-02-12 | AbbVie Deutschland GmbH & Co. KG | Modulators of 5-HT receptors and methods of use thereof |
WO2012030953A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level |
US20120309796A1 (en) | 2011-06-06 | 2012-12-06 | Fariborz Firooznia | Benzocycloheptene acetic acids |
WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
CA3093189A1 (en) | 2018-03-07 | 2019-09-12 | Bayer Aktiengesellschaft | Identification and use of erk5 inhibitors |
WO2024091983A1 (en) * | 2022-10-25 | 2024-05-02 | Artus Therapeutics, Inc. | Therapeutic agents for enhancing epithelial and/or endothelial barrier function |
CN116253627A (zh) * | 2022-12-27 | 2023-06-13 | 大连双硼医药化工有限公司 | 一种合成2-溴-6-羟基苯甲醛的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4132710A (en) | 1976-12-20 | 1979-01-02 | Ayerst, Mckenna And Harrison, Ltd. | [2]Benzopyrano[3,4-c]pyridines and process therefor |
US4132709A (en) * | 1976-12-20 | 1979-01-02 | Ayerst, Mckenna & Harrison, Ltd. | [2]Benzopyrano[4,3-c]pyridine derivatives and process therefor |
NL8005754A (nl) * | 1980-10-18 | 1982-05-17 | Akzo Nv | Benzo 4,5 pyrano 2,3-c pyrrool derivaten. |
US4666916A (en) * | 1985-11-08 | 1987-05-19 | Ciba-Geigy Corporation | Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents |
US5049564A (en) * | 1989-11-17 | 1991-09-17 | Abbott Laboratories | 5-HT selective agents |
ES2090119T3 (es) * | 1988-12-15 | 1996-10-16 | Abbott Lab | Agentes selectivos de 5-ht. |
GB8917333D0 (en) * | 1989-07-28 | 1989-09-13 | Merck Sharp & Dohme | Therapeutic agents |
CA2118920A1 (en) * | 1991-10-24 | 1993-04-29 | Arthur G. Romero | Benzo-isoquinoline derivatives and analogs and their use in therapeutics |
FR2722194B1 (fr) * | 1994-07-06 | 1996-08-23 | Adir | Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent |
-
2008
- 2008-09-10 TW TW097134706A patent/TW200924752A/zh unknown
- 2008-09-15 RU RU2010115337/04A patent/RU2010115337A/ru unknown
- 2008-09-15 NZ NZ583627A patent/NZ583627A/en not_active IP Right Cessation
- 2008-09-15 KR KR1020107008334A patent/KR20100072027A/ko not_active Application Discontinuation
- 2008-09-15 CA CA2698436A patent/CA2698436A1/en not_active Abandoned
- 2008-09-15 CN CN200880107460.7A patent/CN101801980B/zh not_active Expired - Fee Related
- 2008-09-15 US US12/678,184 patent/US20100210680A1/en not_active Abandoned
- 2008-09-15 JP JP2010524519A patent/JP5447380B2/ja not_active Expired - Fee Related
- 2008-09-15 BR BRPI0816992 patent/BRPI0816992A2/pt not_active Application Discontinuation
- 2008-09-15 EP EP08804190A patent/EP2203454A1/en not_active Withdrawn
- 2008-09-15 WO PCT/EP2008/062229 patent/WO2009037220A1/en active Application Filing
- 2008-09-15 MX MX2010002900A patent/MX2010002900A/es not_active Application Discontinuation
- 2008-09-15 AU AU2008300607A patent/AU2008300607B2/en not_active Ceased
- 2008-09-16 PE PE2008001616A patent/PE20090704A1/es not_active Application Discontinuation
- 2008-09-16 AR ARP080104015A patent/AR068521A1/es unknown
- 2008-09-16 CL CL2008002767A patent/CL2008002767A1/es unknown
-
2010
- 2010-03-17 CO CO10031803A patent/CO6260138A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200924752A (en) | 2009-06-16 |
JP2010539139A (ja) | 2010-12-16 |
AR068521A1 (es) | 2009-11-18 |
JP5447380B2 (ja) | 2014-03-19 |
MX2010002900A (es) | 2010-03-31 |
RU2010115337A (ru) | 2011-10-27 |
CO6260138A2 (es) | 2011-03-22 |
CL2008002767A1 (es) | 2009-03-06 |
US20100210680A1 (en) | 2010-08-19 |
CN101801980B (zh) | 2014-03-12 |
CN101801980A (zh) | 2010-08-11 |
NZ583627A (en) | 2011-08-26 |
CA2698436A1 (en) | 2009-03-26 |
PE20090704A1 (es) | 2009-06-20 |
AU2008300607B2 (en) | 2013-08-22 |
EP2203454A1 (en) | 2010-07-07 |
WO2009037220A1 (en) | 2009-03-26 |
AU2008300607A1 (en) | 2009-03-26 |
KR20100072027A (ko) | 2010-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTC2140867I2 (lt) | Farmacinė kompozicija | |
BRPI0721651A2 (pt) | Composição farmacêutica | |
BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0816992A2 (pt) | Derivado heterocíclico tricícloco, e, composição farmacêutica | |
BRPI0715712A2 (pt) | Composição farmacêutica | |
DK2207773T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning deraf. | |
DK1940467T3 (da) | Lægemiddelsammensætning med langvarig frigivelse | |
BRPI0719393A2 (pt) | Composição farmacêutica | |
DK2164844T3 (da) | Pyrimidinyl-pyridazinonderivater | |
DK2209786T3 (da) | Pyrimidinsubstituerede purinderivater | |
BRPI1013642A2 (pt) | derivado de triazina e composição farmacêutica compreendendo o mesmo | |
DK3492069T3 (da) | Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid | |
DK2120884T3 (da) | Farmaceutisk sammensætning | |
BRPI0813836A2 (pt) | Derivados pirazólicos | |
DK2254873T3 (da) | Benzodiazepinforbindelse og farmaceutisk sammensætning. | |
BRPI0809346A2 (pt) | Compostos derivados substituídos de imidazopiridina e composição farmacêutica contendo os mesmos | |
ATE518837T1 (de) | Indazolamidderivate | |
BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0720234A2 (pt) | Composição farmacêutica | |
BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
BRPI0905369A2 (pt) | Composição farmacêutica, composição e kit compartimentado | |
DK2152370T3 (da) | Aryletherpyridazinonderivater | |
BRPI0807078A2 (pt) | Composto, e, formulação farmacêutica | |
BRPI0817833A2 (pt) | Composição farmacêutica antimalárica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |